The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Growth In Market Size Of The Precision Psychiatry Market During 2026–2030?
The precision psychiatry market has experienced substantial expansion in recent times. Its value is projected to increase from $4.99 billion in 2025 to $5.72 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.7%. This historic growth can be primarily linked to the rising occurrence of mental health disorders, the increasing limitations of trial-and-error prescribing methods, the broadening scope of psychiatric research initiatives, the enhanced availability of neuroimaging technologies, and the early integration of pharmacogenomics in psychiatry.
The precision psychiatry market size is anticipated to undergo significant expansion in the foreseeable future, projected to reach $9.81 billion in 2030, at a compound annual growth rate (CAGR) of 14.4%. This projected growth throughout the forecast period stems from various factors, including increased investments in precision medicine platforms, the growing adoption of AI-enabled diagnostics, the broadening of digital mental health solutions, a rising demand for personalized psychiatric care, and an enhanced focus on preventive mental health strategies. Notable trends during this period are expected to encompass an increasing adoption of biomarker-guided treatment pathways, a rising utilization of digital phenotyping tools, greater integration of genetic and neuroimaging data, the expansion of AI-driven clinical decision support, and an elevated focus on personalized mental health monitoring.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30359&type=smp
What Market Drivers Are Helping Shape The Precision Psychiatry Market Expansion?
The growing occurrence of mental health conditions is anticipated to fuel the expansion of the precision psychiatry market moving ahead. These conditions encompass various issues, including depression, anxiety, and bipolar disorder, which impact an individual’s mood, thought processes, and conduct. The rise in mental health disorders is attributed to a greater number of people experiencing psychological challenges stemming from societal, financial, and environmental factors, alongside enhanced screening methods and increased public knowledge leading to higher diagnostic figures. Precision psychiatry tackles mental health issues by facilitating data-informed, individualized treatment approaches that enhance diagnostic precision and therapeutic results. For example, in November 2023, data from NHS England, the UK-based publicly funded national health authority, indicated that the probability rate of a mental disorder for individuals aged 20 to 23 years increased from 18.7% in 2022 to 21.6% in 2023. Consequently, the escalating prevalence of mental health disorders is stimulating the growth of the precision psychiatry market.
How Are Different Segment Groups Identified Within The Precision Psychiatry Market?
The precision psychiatry market covered in this report is segmented –
1) By Therapeutic Approaches: Pharmacotherapy, Psychotherapy, Neurostimulation, Digital Therapeutics, Combination Therapies
2) By Technology: Genetic Testing, Biomarker Analysis, Brain Imaging Techniques, Wearable Devices, Artificial Intelligence And Machine Learning Solutions
3) By Disorders: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Post-Traumatic Stress Disorder (PTSD)
4) By Application: Diagnosis, Treatment, Research
5) By End User: Clinics, Hospitals, Research Institutes, Pharmaceutical Companies, Home Care Settings
Subsegments:
1) By Pharmacotherapy: Antidepressant Medications, Antipsychotic Medications, Mood Stabilizers, Anxiolytic Medications, Stimulant Medications
2) By Psychotherapy: Cognitive Behavioral Therapy, Interpersonal Therapy, Psychodynamic Therapy, Dialectical Behavior Therapy, Mindfulness-Based Therapy
3) By Neurostimulation: Transcranial Magnetic Stimulation, Electroconvulsive Therapy, Vagus Nerve Stimulation, Deep Brain Stimulation, Transcranial Direct Current Stimulation
4) By Digital Therapeutics: Mobile Application-Based Therapy, Virtual Reality Therapy, Web-Based Cognitive Behavioral Programs, Remote Patient Monitoring Tools, Artificial Intelligence-Guided Interventions
5) By Combination Therapies: Pharmacotherapy And Psychotherapy Combination, Pharmacotherapy And Neurostimulation Combination, Pharmacotherapy And Digital Therapeutics Combination, Psychotherapy And Neurostimulation Combination, Multimodal Precision Treatment Programs
Which Trends Are Shaping The Precision Psychiatry Market Landscape?
Leading companies within the precision medicine software market are concentrating on developing sophisticated solutions, such as digital healthcare, to optimize the creation of digital health products, thereby reducing both time and costs. Digital healthcare itself involves the utilization of digital technologies and tools to deliver, manage, and enhance healthcare services and their outcomes. For instance, in July 2024, Huma Therapeutics Ltd, a UK-based digital health company, unveiled its Cloud Platform. This platform is designed to make digital-first healthcare widely available by enabling the swift, no-code development and deployment of regulated health applications powered by artificial intelligence (AI). The platform is equipped with ready-made components, integrates with various devices, and complies with significant regulatory standards (FDA Class II, EU MDR IIb, Saudi FDA C), allowing organizations of any scale to offer effective and cost-efficient digital health solutions. Ultimately, the Huma cloud platform boosts digital health innovation, extends access, and supports proactive, artificial intelligence (AI)-driven care and research.
Which Companies Form The Competitive Landscape Of The Precision Psychiatry Market?
Major companies operating in the precision psychiatry market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Pfizer Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Otsuka Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Illumina Inc., ARUP Laboratories Inc., Sumitomo Dainippon Pharma Company Limited, QIAGEN N.V., Neurocrine Biosciences Inc., Tempus Labs Inc., Myriad Genetics Inc., MedGenome Labs Ltd., Genomind Inc.
Access The Complete Precision Psychiatry Market Report:
https://www.thebusinessresearchcompany.com/report/global-precision-psychiatry-market-report
Which Region Leads The Precision Psychiatry Market By Size?
North America was the largest region in the precision psychiatry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision psychiatry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Precision Psychiatry Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=30359&type=smp
Browse Through More Reports Similar to the Global Precision Psychiatry Market 2026, By The Business Research Company
Syndicated Loans Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/syndicated-loans-global-market-report
Revenue Based Financing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/revenue-based-financing-global-market-report
Debt Financing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/debt-financing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
